Lynn Malec – The New Director of the CCBD and Pharmacy at Children’s Wisconsin
Versiti Inc shared on LinkedIn:
”Versiti is proud to announce the promotion of Lynn Malec, MD, MSc, to Program Director of the Comprehensive Center for Bleeding Disorders (CCBD) and Pharmacy at Children’s Wisconsin.
Since joining Versiti in 2016, Dr. Malec has led transformative advances in bleeding disorder care, including launching our gene therapy program for hemophilia B, which made Versiti one of the first centers in the U.S. to administer the FDA-approved therapy HEMGENIX.
Her internationally recognized research and compassionate leadership continue to expand access to breakthrough treatments and whole-person care for patients and families.
Learn more about our commitment to advancing hope through science.”
More winner stories featured in Hemostasis Today.
-
Jul 2, 2026, 11:11Safaa Hilal: Improving Postpartum Hemorrhage Outcomes Through Early Warning Scores
-
Jul 2, 2026, 11:10Maria Khan Junaidi: How Age Influences Intracerebral Hemorrhage Outcomes
-
Jul 2, 2026, 10:58Heghine Khachatryan: What Is Your Position on the Voluntary or Financially Compensated Blood Donation Model
-
Jul 2, 2026, 10:51Faces of Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jul 2, 2026, 10:44Priya Sriskandarajah: Understanding Anemia of Chronic Disease in Clinical Practice
-
Jul 2, 2026, 10:42Flora Peyvandi: Germline-Targeting Vaccines for HIV
-
Jul 2, 2026, 10:29Nisar Ahmed: The Evolution of Anticoagulation Therapy
-
Jul 2, 2026, 09:24Paschalis Evangelidis: Presenting Real-World Evidence to Improve Outcomes in TMA at EHA 2026
-
Jul 2, 2026, 09:09Mihaela Cordeanu: Can D-dimer Help Diagnose Splanchnic Vein Thrombosis?